Sho-seiryu-to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal allergy model rats

Allergology International

Volumn 58, Issue 1, 2009, Pages 81-88

  Das, Asish Kumar ^a   Mizuguchi, Hiroyuki ^a   Kodama, Madoka ^a   Dev, Shrabanti ^a   Umehara, Hayato ^a   Kitamura, Yoshiaki ^a   Matsushita, Chiyo ^a   Takeda, Noriaki ^a   Fukui, Hiroyuki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Allergy; Gene expression; Histamine H1 receptors; Histamine signaling; Histidine decarboxylase; Th2 cytokines

Indexed keywords

HISTAMINE H1 RECEPTOR; HISTIDINE DECARBOXYLASE; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; SHO SEIRYU TO; TOLUENE DIISOCYANATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; HISTAMINE METABOLISM; MALE; NONHUMAN; NOSE ALLERGY; NOSE MUCOSA; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 65449137864     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-07-526     Document Type: Article

References (52)

1. von Mutius E. The raising trends in asthma and allergic disease. Clin Exp Allergy 1998;28:45-9.
2. Lee SI, Shin MH, Lee HB et al. Prevalence of symptoms of asthma and other allergic diseases in Korean children: a nation wide questionnaire survey. J Korean Med Sci 2001;16:155-64.
3. Hill SJ, Ganellin CR, Timmerman H et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997;49:253-78.
4. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000;275:36781-6.
5. Martin JG, Suzuki M, Ramos-Barbon D, Isogai S. T cell cytokines: animal models. Paediatr Respir Rev 2004;5:S47-51.
6. Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P. Il-4 induces allergy like inflammatory disease and alters T cell development in transgenic mice. Cell 1990;62:457-67.
7. Wills-Karp M, Luyimbazi J, Xu X et al. IL-13 central mediator of allergic asthma. Science 1998;282:2258-61.
8. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhanches proliferation and mediator release in mature human must cells. Proc Natl Acad Sci U S A 1999;96:8080-5.
9. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002;26:202-8.
10. Marone G, Granata F, Spadaro G, Genovese A, Triggiani M. The histamine-cytokine network in allergic inflammation. J Allergy Clin Immunol 2003;112:S83-8.
11. Igaz P, Novak I, Lazar E, Horvath B, Heninger E, Faauls A. Bidirectional communication between histamine and cytokines. Inflamm Res 2001; 50:123-8.
12. Abdelaziz M, Devalia J, Khair O, Bayram H, Prior A, Davies R. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1998; 101:410-20.
13. Fujikura T, Shimosawa T, Yakuo I. Regulatory effect of histamine H1 receptor antagonists on the expression or messenger RNA encoding CC chemokines in human nasal mucosa. J Allergy Clin Immunol 2001; 107:123-8.
14. Abe Y, Takeda N, Irifune M et al. Effects of capsaicin desensitization on nasal allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guinea pigs. Acta Otolaryngol 1992;112:703-9.
15. Kitamura Y, Miyoshi A, Murata Y, Kalubi B, Fukui H, Takeda N. Effect of glucocorticoid on upregulation of histamine H1 receptor mRNA in nasal mucosa of rats sensitized by exposure to toluene diisocyanate. Acta Otolaryngol 2004;124:1053-8.
16. Kitamura Y, Das AK, Murata Y et al. Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats. Allergol Int 2006; 55:279-86.
17. Ban M, Morel G, Langonne I, Huguet N, Pepin E, Binet S. TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology 2006;218:39-47.
18. Mapp C, Boschetto P, Miotto D, De Rosa E, Fabbri LM. Mechanisms of occupational asthma. Ann Allergy Asthma Immunol 1999; 83:645-64.
19. Wisnewski AV, Redlich CA. Recent developments in di-isocyanate asthma. Curr Opin Allergy Clin Immunol 2001; 1:169-75.
20. Maestrelli P, Saetta M, Mapp C, Fabbri LM. Diagnostic basis of occupational asthma. J Investig Allergol Clin Immunol 1997; 7:316-7.
21. Sakaguchi M, Mase A, Iizuka A et al. Further pharmacological study on Sho-seiryu-to as an antiallergic. Methods Find Exp Clin Pharmacol 1997;19:707-13.
22. Tanaka A, Ohashi Y, Kakinoki Y et al. The herbal medicine shoseiryu-to inhibits allergen-induced synthesis of tumour necrosis factor alpha by peripheral blood mono-nuclear cells in patients with perennial allergic rhinitis. Acta Otolaryngol Suppl 1998; 538:118-25.
23. Yang SH, Hong CY, Yu CL. Decreased serum IgE level, decreased IFN-gamma and IL-5 but increased IL-10 production, and suppressed cyclooxygenase 2 mRNA expression in patients with perennial allergic rhinitis after treatment with a new mixed formula of Chinese herbs. Int Immunopharmacol 2001;1:1173-82.
24. Kao ST, Wang SD, Wang JY, Yu CK, Lei HY. The effect of Chinese herbal medicine, xiao-qing-long tang (XQLT), on allergen-induced bronchial inflammation in mite-sensitized mice. Allergy 2000; 55:1127-33.
25. Ikeda Y, Kaneko A, Yamamoto M, Ishige A, Sasaki H. Possible involvement of suppression of Th2 differentiation in the anti-allergic effect of Sho-seiryu-to in mice. Jpn J Pharmacol 2002;90:328-36.
26. Ko E, Rho S, Lee EJ et al. Traditional Korean medicine (SCRT) modulate Th1/Th2 specific cytokine production in mice CD4+ T cell. J Ethnopharmacol 2004;92:121-8.
27. Ko E, Rho S, Cho C et al. So-Cheong-Ryong-Tang, traditional Korean medicine, suppresses Th2 lineage development. Biol Pharm Bull 2004;27:739-43.
28. Sakaguchi M, Iizuka A, Yuzurihara M et al. Pharmacological characteristics of Sho-seiryu-to, an antiallergic Kampo medicine without effects on histamine H1 receptors and muscarinic cholinergic system in the brain. Methods Find Exp Clin Pharmacol 1996;18:41-7.
29. Umesato Y, Iikura Y, Nakamura Y. [Ashmatic children and Chinese medicine. Scientific study of Shoseiryuto and Saibokuto]. Arerugi [Jpn J Allergol] 1984;33:1047-52(in Japanese).
30. Tanaka K, Okamoto Y, Nagaya Y et al. A nasal allergy model developed in the guinea pig by intranasal application of 2, 4-toluene diisocyanate. Int Arch Allergy Appl Immunol 1998;85:392-7.
31. The Rheumatism and Allergy Information Center. [The Japanese Practical Guideline of Allergic Rhinitis]. Available from: http://www.allergy.go.jp/allergy/guideline/04/index.html (in Japanese).
32. Irifune M. [Effect of sympathetic denervation in guinea pigs with nasal hypersensitivity]. Jibirinsho [Practica Oto-Rhino-Laryngologica] 1989;82:719-27(in Japanese).
33. Nakasaki T, Masuyama K, Fukui H et al. Effects of PAF on histamine H1 receptor mRNA expression in rat trigeminal ganglia. Prostaglandins Other Lipid Mediat 1999;58:29-41.
34. Takeda N, Kalubi B, Abe Y, Irifune M, Ogino S, Matsunaga T. Neurogenic inflammation in nasal allergy: histochemical and pharmacological studies in guinea pigs. A review. Acta Otolaryngol Suppl 1993; 501:21-4.
35. Murata Y, Miyoshi A, Kitamura Y, Takeda N, Fukui H. Up-regulation of histamine H (1) receptors in an allergic rat nasal mucosa model. Inflamm Res 2004;53:S11-2.
36. Dinh QT, Cryer A, Dinh S et al. Transcriptional upregulation of histamine receptor-1 in epithelial, mucus and inflammatory cells in perennial allergic rhinitis. Clin Exp Allergy 2005; 35:1443-8.
37. Bryce PJ, Mathias CB, Harrison KL, Watanabe T, Geha RS, Oettgen HC. The H1 histamine receptor regulates allergic lung responses. J Clin Invest 2006;116:1624-32.
38. Iriyoshi N, Takeuchi K, Yuta A, Ukai K, Sakakura Y. Increased expression of histamine H1 receptor mRNA in allergic rhinitis. Clin Exp Allergy 1996;26:379-85.
39. Hamano N, Terada N, Maesaka K et al. Expression of histamine receptors in nasal epithelial cells and endothelial cells-the effects of sex hormones. Int Arch Allergy Immunol 1998;115:220-7.
40. Hirata N, Takeuchi K, Ukai K, Sakakura Y. Expression of histidine decarboxylase messenger RNA and histamine N-methyltransferase messenger RNA in nasal allergy. Clin Exp Allergy 1999;29:76-83.
41. Yamauchi K. [Regulation of gene expression of L-histidine decarboxylase and histamine N-methyltransferase, and its relevance to the pathogenesis of bronchial asthma]. Nippon Rinsho 1996;54:377-88(in Japanese).
42. Matsuno H, Alcordo MJ, Yoo TJ. T Cell Modulating Herbal Medicine. J Allergy Clin Immunol 2000;105:S158.
43. Nagai T, Arai Y, Emori M et al. Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model. Int Immunopharmacol 2004; 4:1353-65.
44. Zurawski SM, Chomarat P, Djossou O et al. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 1995;23:13869-78.
45. Brinkmann V, Kristofic C. TCR-stimulated naive human CD4+45RO. T cells develop into effector cells that secrete IL-13, IL-5, and IFN-γ, but not IL-4, and help efficient IgE production by B cells. J Immunol 1995;154:3078-87.
46. Kimata H, Fujimoto M, Furusho K. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in neph-rotic syndrome. Eur J Immunol 1995; 25:1497-501.
47. Ghaffar O, Laberge S, Jacobson MR et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997; 17:17-24.
48. Johnson VJ, Yucesoy B, Reynolds JS et al. Inhalation of toluene diisocyanate vapor induces allergic rhinitis in mice. J Immunol 2007;179:1864-71.
49. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A 1999;96:8080-5.
50. Yamaguchi M, Sayama K, Yano K et al. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol 1999; 162:5455-65.
51. Lagier B, Lebel B, Bousquest J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-γ) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 1997;108:545-51.
52. Krouwels FH, Hol BE, Lutter R et al. Histamine affects interleukin-4, interleukin-5, and interferon-γ production by human T cell clones from airways and blood. Am J Respir Cell Mol Biol 1998;18:721-30.